Skip to main content
Premium Trial:

Request an Annual Quote

Veronica Jordan, David Schreiber

Vermillion has appointed Veronica Jordan and David Schreiber to its board of directors.

Jordan is the former CEO of Medelle. Prior to that, she held executive positions at Parexel Internation as well as leadership roles at Biogen Idec and Baxter International.

Schreiber is a healthcare consultant. He was previously senior vice president and chief financial officer of Dianon Systems, which was acquired by Laboratory Corporation of America in 2003.

The Scan

Review of Approval Process

Stat News reports the Department for Health and Human Services' Office of the Inspector General is to investigate FDA's approval of Biogen's Alzheimer's disease drug.

Not Quite Right

A new analysis has found hundreds of studies with incorrect nucleotide sequences reported in their methods, according to Nature News.

CRISPR and mRNA Together

Time magazine reports on the use of mRNA to deliver CRISPR machinery.

Nature Papers Present Smartphone Platform for DNA Diagnosis of Malaria, Mouse Lines for Epigenomic Editing

In Nature this week: a low-cost tool to detect infectious diseases like malaria, and more.